1
|
Jaradat DMM, Al-Karablieh N, Zaarer BHM, Li W, Saleh KKY, Rasras AJ, Abu-Romman S, O'Brien-Simpson NM, Wade JD. Human glucose-dependent insulinotropic polypeptide (GIP) is an antimicrobial adjuvant re-sensitising multidrug-resistant Gram-negative bacteria. Biol Chem 2021; 402:513-524. [PMID: 33938181 DOI: 10.1515/hsz-2020-0351] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Accepted: 12/09/2020] [Indexed: 11/15/2022]
Abstract
Increasing antibiotic resistance in Gram-negative bacteria has mandated the development of both novel antibiotics and alternative therapeutic strategies. Evidence of interplay between several gastrointestinal peptides and the gut microbiota led us to investigate potential and broad-spectrum roles for the incretin hormone, human glucose-dependent insulinotropic polypeptide (GIP) against the Enterobacteriaceae bacteria, Escherichia coli and Erwinia amylovora. GIP had a potent disruptive action on drug efflux pumps of the multidrug resistant bacteria E. coli TG1 and E. amylovora 1189 strains. The effect was comparable to bacterial mutants lacking the inner and outer membrane efflux pump factor proteins AcrB and TolC. While GIP was devoid of direct antimicrobial activity, it has a potent membrane depolarizing effect, and at low concentrations, it significantly potentiated the activity of eight antibiotics and bile salt by reducing MICs by 4-8-fold in E. coli TG1 and 4-20-fold in E. amylovora 1189. GIP can thus be regarded as an antimicrobial adjuvant with potential for augmenting the available antibiotic arsenal.
Collapse
Affiliation(s)
- Da'san M M Jaradat
- Faculty of Science, Department of Chemistry, Al-Balqa Applied University, P.O. Box 19117, Al-Salt, Jordan
| | - Nehaya Al-Karablieh
- Faculty of Agriculture, Department of Plant Protection, The University of Jordan, Amman, Jordan
- Hamdi Mango Center for Scientific Research, The University of Jordan, Amman, Jordan
| | - Basmah H M Zaarer
- Faculty of Science, Department of Chemistry, Al-Balqa Applied University, P.O. Box 19117, Al-Salt, Jordan
| | - Wenyi Li
- The Bio21 Institute of Molecular Science and Biotechnology, Melbourne Dental School, Centre for Oral Health Research, University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Khalil K Y Saleh
- Faculty of Science, Department of Chemistry, Al-Balqa Applied University, P.O. Box 19117, Al-Salt, Jordan
| | - Anas J Rasras
- Faculty of Science, Department of Chemistry, Al-Balqa Applied University, P.O. Box 19117, Al-Salt, Jordan
| | - Saeid Abu-Romman
- Faculty of Agricultural Technology, Department of Biotechnology, Al-Balqa Applied University, P.O. Box 19117, Al-Salt, Jordan
| | - Neil M O'Brien-Simpson
- The Bio21 Institute of Molecular Science and Biotechnology, Melbourne Dental School, Centre for Oral Health Research, University of Melbourne, Melbourne, Victoria 3010, Australia
| | - John D Wade
- School of Chemistry, University of Melbourne, Melbourne, Victoria 3010, Australia
- Howard Florey Research Laboratories, Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 3010, Australia
| |
Collapse
|